Knight Therapeutics Inc. (TSX:GUD)
7.38
-0.15 (-1.99%)
Apr 28, 2026, 4:00 PM EST
Knight Therapeutics Employees
Knight Therapeutics had 830 employees as of December 31, 2025. The number of employees increased by 85 or 11.41% compared to the previous year.
Employees
830
Change (1Y)
85
Growth (1Y)
11.41%
Revenue / Employee
542.27K CAD
Profits / Employee
-6.47K CAD
Market Cap
739.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Verano Holdings | 3,800 |
| Cresco Labs | 2,900 |
| Cipher Pharmaceuticals | 5 |
| Cronos Group | 610 |
| TerrAscend | 1,038 |
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
Knight Therapeutics News
- 13 days ago - Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 5 weeks ago - Knight Amends Normal Course Issuer Bid - GlobeNewsWire
- 5 weeks ago - Knight Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results - GlobeNewsWire
- 6 weeks ago - Notice of Knight Therapeutics' Fourth Quarter and Year End 2025 Results Conference Call - GlobeNewsWire
- 2 months ago - Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil - GlobeNewsWire
- 4 months ago - Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris - GlobeNewsWire
- 6 months ago - Knight Therapeutics Reports Third Quarter 2025 Results - GlobeNewsWire